LOADING
Comparing Pfizer Inc (PFE) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | NKE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $152.7B | $80.1B |
| P/E Ratio | 19.8 | 31.7 |
| Forward P/E | 9.2 | 22.5 |
| PEG Ratio | 13.77 | 1.24 |
| EPS | $1.36 | $1.71 |
| Revenue Growth (YoY) | -1.2% | 0.6% |
| Profit Margin | 12.4% | 5.4% |
| Return on Equity | 8.9% | 17.9% |
| Dividend Yield | 6.30% | 2.89% |
| Beta | 0.41 | 1.29 |
| 52-Week High | $27.94 | $78.71 |
| 52-Week Low | $19.50 | $50.99 |
| Volume | -- | -- |
Pfizer Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.